MOVe-Out RCT | Molnupiravir for COVID-19 in Outpatients
Spoon Feed
Molnupiravir is an oral antiviral drug that has been shown to decrease risk of hospitalization or death at 29 days in patients with mild to moderate COVID-19 who are at risk for progression to severe disease